Clinical trials
Observational Lung Diseases, Obstructive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2005 | 6 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Unknown status | 8 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 18 |
| University of Michigan | 5 |
| AstraZeneca | 2 |
| Catholic University of the Sacred Heart | 2 |
| Hacettepe University | 2 |
| National Taiwan University Hospital | 2 |
| RWTH Aachen University | 2 |
| Royal Brompton & Harefield NHS Foundation Trust | 2 |
| Sykehuset Telemark | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Obstructive | 67 |
| Pulmonary Disease, Chronic Obstructive | 35 |
| Asthma | 14 |
| Lung Diseases | 13 |
| Cardiovascular Diseases | 5 |
| Emphysema | 5 |
| Hypertension | 4 |
| Inflammation | 4 |
| Respiratory Tract Diseases | 4 |
| Bronchitis | 3 |
Trials
Showing 51 to 67 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.